TELA Bio, Inc. (TELA) Misses Q1 EPS by 5c

TELA Bio, Inc. (NASDAQ: TELA) reported Q1 EPS of ($0.25), $0.05 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $21.05 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
• Kepler Cheuvreux Downgrades Schaeffler AG (SHA:GR) (SFFLY) to Hold
• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight